Solventum Q2 sales up 9.5% organic; adj. EPS $2.55 (+50.9%); plans to separate HIS segment

Solventum Corp

Sales $2.2B, organic +9.5%; GAAP EPS $0.53, adjusted EPS $2.55 (+50.9% YoY).
Operating cash flow $227M, free cash flow $144M (+144% YoY).
Announces intent to separate Health Information Systems business segment.
Raises full-year 2026 guidance for organic sales growth, adjusted EPS, and free cash flow.
CEO Bryan Hanson cites strong execution and transformation progress.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.